Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Verbascoside represses malignant phenotypes of esophageal squamous cell carcinoma cells by inhibiting CDC42 via the HMGB1/RAGE axis.

Human & experimental toxicology - 1 Jan 2000

Ji Mingming, Sun Jian, Zhao Jun

Abstract excerpt

BACKGROUND: As an aggressive human malignancy, esophageal squamous cell carcinoma (ESCC) is prevalent globally, especially in China. Verbascoside (VE) exerts anti-cancer effects in several human cancers. This work was to investigate the effects of VE on ESCC cells. METHODS: Esophageal squamous cell carcinoma cell proliferation, apoptosis, migration, and invasion were assessed by CCK-8, TUNEL, and Transwell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to cdc42 GTP-Binding Protein
Share to Esophageal Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Esophageal Squamous Cell Carcinoma

Share to Glucosides

Share to HMGB1 Protein

Share to Neoplasm Invasiveness

Share to Polyphenols

Share to Receptor for Advanced Glycation End Products

Source

Identifiers

PMID: 36112883
DOI: 10.1177/09603271221127429

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Verbascoside represses malignant phenotypes of esophageal squamous cell carcinoma cells by inhibiting CDC42 via the HMGB1/RAGE axis.PMID 36112883Read ↗

MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGDSemantic proximity Read ↗

SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53Semantic proximity Read ↗

DpdtbA-Induced Growth Inhibition in Human Esophageal Cancer Cells Involved Inactivation of the p53/EGFR/AKT PathwaySemantic proximity Read ↗

CTSG Suppresses Colorectal Cancer Progression through Negative Regulation of Akt/mTOR/Bcl2 Signaling PathwaySemantic proximity Read ↗

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian CancersSemantic proximity Read ↗

RAGE signaling inhibition prevents the malignant phenotypes of pancreatic ductal adenocarcinoma cells.Semantic proximity Read ↗

The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesisSemantic proximity Read ↗

A Key Role for Early Growth Response-1 and Nuclear Factor-κB in Mediating and Maintaining GRO/CXCR2 Proliferative Signaling in Esophageal CancerSemantic proximity Read ↗

Ginsenoside Compound K Inhibits the Proliferation, Migration and Invasion of Eca109 cell via VEGF-A/Pi3k/Akt PathwaySemantic proximity Read ↗

Dihydroartemisinin downregulates the expression of COX-2 in esophageal squamous cell carcinoma through ROS/MAPK/Sp1 axisSemantic proximity Read ↗

Elaiophylin Targets EIF4B to Regulate the Proliferation, Invasion, and Apoptosis of Esophageal Squamous Cell Carcinoma via the PI3K/AKT Signaling PathwaySemantic proximity Read ↗

S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.